FDA Import Refusal W69-5020849-7/21/1 — Shilpa Pharma Lifesciences Limited
The FDA refused shipment W69-5020849-7/21/1 from Shilpa Pharma Lifesciences Limited (India) on February 9, 2023. The refused product falls under Drugs and Biologics — INHIBITOR (GROWTH FACTOR) N.E.C.. Cited charge: 75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- February 9, 2023
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60YIY99 INHIBITOR (GROWTH FACTOR) N.E.C.
- Charges
- 75